Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate

Veterinary Microbiology

Volumn 130, Issue 3-4, 2008, Pages 330-337

  Heinzmann, Julia ^a   Wilkens, Mirja ^a   Dohmann, Karen ^a   Gerlach, Gerald F ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Paratuberculosis; Recombinant M. bovis BCG; Vaccination

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BCG VACCINATION; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; MOLECULAR CLONING; MOUSE; MPT GENE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; OPERON; PARATUBERCULOSIS; PATHOGENICITY;

ANIMALS; BCG VACCINE; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC ENGINEERING; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS; OPERON; TRANSCRIPTION, GENETIC; TUBERCULOSIS VACCINES; VACCINES, SYNTHETIC;

ANIMALIA; MUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; MYCOBACTERIUM BOVIS BCG;

EID: 47049127731     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2008.01.014     Document Type: Article

References (31)

1. Bloom B.R., and Fine P.E.M. The BCG experience: implications for future vaccines against tuberculosis. In: Bloom B.R. (Ed). Tuberculosis: Pathogenesis, Protection, and Control (1994), ASM Press, Washington, DC 531-557
2. Boyer H.W., and Roulland-Dussoix D. A complementation analysis of the restriction and modification of DNA in Escherichia coli. J. Mol. Biol. 41 (1969) 459-472
3. Brandt L., Feino C.J., Weinreich O.A., Chilima B., Hirsch P., Appelberg R., and Andersen P. Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect. Immun. 70 (2002) 672-678
4. Buddle B.M., Aldwell F.E., Skinner M.A., De Lisle G.W., Denis M., Vordermeier H.M., Hewinson R.G., and Wedlock D.N. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23 (2005) 3581-3589
5. Collins F.M. Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species. Infect. Immun. 4 (1971) 688-696
6. Dennehy M., Bourn W., Steele D., and Williamson A.L. Evaluation of recombinant BCG expressing rotavirus VP6 as an anti-rotavirus vaccine. Vaccine 25 (2007) 3646-3657
7. Dennehy M., and Williamson A.L. Factors influencing the immune response to foreign antigen expressed in recombinant BCG vaccines. Vaccine 23 (2005) 1209-1224
8. Dietrich G., Viret J.F., and Hess J. Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments. Vaccine 21 (2003) 667-670
9. Feller M., Huwiler K., Stephan R., Altpeter E., Shang A., Furrer H., Pfyffer G.E., Jemmi T., Baumgartner A., and Egger M. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Infect Dis. 7 (2007) 607-613
10. Granger K., Moore R.J., Davies J.K., Vaughan J.A., Stiles P.L., Stewart D.J., and Tizard M.L. Recovery of Mycobacterium avium subspecies paratuberculosis from the natural host for the extraction and analysis in vivo-derived RNA. J. Microbiol. Methods 57 (2004) 241-249
11. Harris N.B., and Barletta R.G. Mycobacterium avium subsp. paratuberculosis in veterinary medicine. Clin. Microbiol. Rev. 14 (2001) 489-512
12. Hewinson R.G., Vordermeier H.M., Smith N.H., and Gordon S.V. Recent advances in our knowledge of Mycobacterium bovis: a feeling for the organism. Vet. Microbiol. 112 (2006) 127-139
13. Himmelrich H., Lo-Man R., Winter N., Guermonprez P., Sedlik C., Rojas M., Monnaie D., Gheorghiu M., Lagranderie M., Hofnung M., Gicquel B., Clement J.M., and Leclerc C. Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: MalE. Vaccine 18 (2000) 2636-2647
14. Huntley J.F., Stabel J.R., Paustian M.L., Reinhardt T.A., and Bannantine J.P. Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection. Infect. Immun. 73 (2005) 6877-6884
15. Koets A., Hoek A., Langelaar M., Overdijk M., Santema W., Franken P., Eden W., and Rutten V. Mycobacterial 70 kD heat-shock protein is an effective subunit vaccine against bovine paratuberculosis. Vaccine 24 (2006) 2550-2559
16. Kohler H., Gyra H., Zimmer K., Drager K.G., Burkert B., Lemser B., Hausleithner D., Cubler K., Klawonn W., and Hess R.G. Immune reactions in cattle after immunization with a Mycobacterium paratuberculosis vaccine and implications for the diagnosis of M. paratuberculosis and M. bovis infections. J. Vet. Med. B Infect. Dis. Vet. Public Health 48 (2001) 185-195
17. Kreeger J.M. Ruminant paratuberculosis-a century of progress and frustration. J. Vet. Diagn. Invest. 3 (1991) 373-382
18. Lesellier S., Palmer S., Dalley D.J., Davé D., Johnson L., Hewinson R.G., and Chambers M.A. The safety and immunogenicity of Bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles). Vet. Immunol. Immunopathol. 112 (2006) 24-37
19. Nasser E.A., and Kaufmann S.H. Improved protection by recombinant BCG. Microbes Infect. 7 (2005) 939-946
20. Patterson C.J., LaVenture M., Hurley S.S., and Davis J.P. Accidental self-inoculation with Mycobacterium paratuberculosis bacterin (Johne's bacterin) by veterinarians in Wisconsin. J. Am. Vet. Med. Assoc. 192 (1988) 1197-1199
21. Pavelka Jr. M.S., and Jacobs Jr. W.R. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J. Bacteriol. 181 (1999) 4780-4789
22. Pym A.S., Brodin P., Majlessi L., Brosch R., Demangel C., Williams A., Griffiths K.E., Marchal G., Leclerc C., and Cole S.T. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat. Med. 9 (2003) 533-539
23. Rodriguez J.G., Mejia G.A., del Portillo P., Patarroyo M.E., and Murillo L.A. Species-specific identification of Mycobacterium bovis by PCR. Microbiology 141 (1995) 2131-2138
24. Rosseels V., Roupie V., Zinniel D., Barletta R.G., and Huygen K. Development of luminescent Mycobacterium avium subsp. paratuberculosis for rapid screening of vaccine candidates in mice. Infect. Immun. 74 (2006) 3684-3686
25. Shin S.J., Wu C.W., Steinberg H., and Talaat A.M. Identification of novel virulence determinants in Mycobacterium paratuberculosis by screening a library of insertional mutants. Infect. Immun. 74 (2006) 3825-3833
26. Stover C.K., Bansal G.P., Hanson M.S., Burlein J.E., Palaszynski S.R., Young J.F., Koenig S., Young D.B., Sadziene A., and Barbour A.G. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J. Exp. Med. 178 (1993) 197-209
27. Stover C.K., de la Cruz C.V., Fuerst T.R., Burlein J.E., Benson L.A., Bennett L.T., Bansal G.P., Young J.F., Lee M.H., Hatfull G.F., Snapper S.B., Barletta R.G., Jacobs W.R., and Bloom B.R. New use of BCG for recombinant vaccines. Nature 351 (1991) 456-460
28. Stratmann J., Dohmann K., Heinzmann J., and Gerlach G.-F. Peptide aMptD-mediated capture PCR for detection of Mycobacterium avium subsp. paratuberculosis in bulk milk samples. Appl. Environ. Microbiol. 72 (2006) 5150-5158
29. Stratmann J., Strommenger B., Goethe R., Dohmann K., Gerlach G.-F., Stevenson K., Li L.L., Zhang Q., Kapur V., and Bull T.J. A 38-kilobase pathogenicity island specific for Mycobacterium avium subsp paratuberculosis encodes cell surface proteins expressed in the host. Infect. Immun. 72 (2004) 1265-1274
30. van Oirschot J.T. Present and future of veterinary viral vaccinology: a review. Vet. Q. 23 (2001) 100-108
31. Young S.L., Slobbe L., Wilson R., Buddle B.M., De Lisle G.W., and Buchan G.S. Environmental strains of Mycobacterium avium interfere with immune responses associated with BCG vaccination. Infect. Immun. 75 (2007) 2833-2840